Twice a year, the Research Mobility Fellowships of the European Joint Programme on Rare Diseases (EJP RD) from the European Reference Networks (ERN) get awarded to prominent researchers or MDs to develop new skills and expertise in a European institution specialized in research on rare diseases.
Eva Coopmans, medical doctor and postdoctoral researcher at the Centre of Endocrine Tumors Leiden (Centrum voor Endocriene Tumoren Leiden), supervised by Prof. A.M. Pereira Arias and Prof. N.R. Biermasz, has been awarded the EJP RD – ERN fellowship for a pilot study ‘GH-secreting pituitary tumours: nip therapy resistance in the bud’. This fellowship will allow her to research the role of AIP and GNAS mutations in treatments with somatostatin analogues in vivo at the William Harvey Research Institute (WHRI), Queen Mary University of London (QMUL), under supervision of Prof. Korbonits, one of the world’s leading figures in the area of rare hereditary pituitary gland tumors.
Oana Danila is an endocrinologist in training from the National Institute for Endocrinology, C.I. Parhon, in Bucharest, Romania. She was awarded the EJP RD – ERN fellowship for a case control study called ‘The influence of Growth Hormone excess secretion on the evolution of Fibrous Dysplasia in patients with McCune Albright Syndrome’. This fellowships will enable her to research the role of growth hormone secretion in fibrous dysplasia in patients suffering from McCune Albright syndrome. She will also be able to gain clinical experience with this cohort in the LUMC under the supervision of Dr. Appelman-Dijkstra, one of the leading experts in metabolic bone diseases.
For more information on the EJP RD Research Mobility Fellowships and financing possibilities, please check: https://www.ejprarediseases.org/our-actions-and-services/funding-opportunities/funded-projects/ern-trainings-2/
The EJP RD initiative received financial support from the European Union’s Horizon 2020 research and innovation programme, grant agreement N˚825575. The LUMC/Endo-ERN is partner of the EJP RD.
On April 15th, LUMC Global and the LUMC’s Obstetrics and Gynecology department organized a very successful expert webinar Innovations in Fetal Therapy. We have published the entire recording of the event online!
Maria Yazdanbakhsh, Professor of Parasitology at the Leiden University Medical Centre (LUMC), has been awarded an ERC Advanced Grant of 2.5 million euros. She will investigate why people in Africa and Southeast Asia respond less to certain vaccines than Europeans. Her goal is to find a solution for low vaccine responses.
Truth be told, the LUMC Global program has been running for a bit more than a year now, but we want to look back at some of our achievements in our slightly more than a year anniversary. Because it has been quite a year for the LUMC Global Initiative in which we have set up multiple projects stimulating international collaboration to work on global health(care) challenges in (bio)medical education and research.